Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $260000.0.

  • ENvue Medical's Other Non-Current Liabilities rose 2264.15% to $260000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260000.0, marking a year-over-year increase of 2264.15%. This contributed to the annual value of $216000.0 for FY2024, which is 46.08% down from last year.
  • As of Q3 2025, ENvue Medical's Other Non-Current Liabilities stood at $260000.0, which was up 2264.15% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Other Non-Current Liabilities registered a high of $4.2 million during Q2 2025, and its lowest value of $206000.0 during Q3 2023.
  • Its 5-year average for Other Non-Current Liabilities is $660631.6, with a median of $223000.0 in 2022.
  • Per our database at Business Quant, ENvue Medical's Other Non-Current Liabilities crashed by 9140.04% in 2022 and then surged by 189090.91% in 2025.
  • Quarter analysis of 5 years shows ENvue Medical's Other Non-Current Liabilities stood at $253000.0 in 2021, then decreased by 11.86% to $223000.0 in 2022, then dropped by 2.69% to $217000.0 in 2023, then dropped by 0.46% to $216000.0 in 2024, then grew by 20.37% to $260000.0 in 2025.
  • Its last three reported values are $260000.0 in Q3 2025, $4.2 million for Q2 2025, and $213000.0 during Q1 2025.